SkinBioTherapeutics launches psoriasis supplement in UK and US

3-Nov-2021

Earlier in 2021, the company conducted a customer study, where participants who self-identified as suffering from psoriasis reported on positive impacts of the food supplement

SkinBioTherapeutics has launched AxisBiotix-Ps, a probiotic food supplement aimed to alleviate the symptoms associated with psoriasis, for UK and US customers from today.

Psoriasis is a chronic condition that affects around 125 million people globally and manifests as itchy, flaky, red skin on any part of the body. AxisBiotix-Ps is a natural blend of selected bacteria aimed to ease these symptoms by reducing inflammation in psoriatic patients. If not addressed, this inflammation could lead to more serious health conditions, including psoriatic arthritis, as well as impacting the individual’s emotional and mental health, relationships and more. Current treatments include topical creams, light therapy, as well as prescription-based systemic treatments, such as injections.

AxisBiotix-Ps was designed based on long-term scientific research into the role of the gut microbiome on overall health, including the immune system. The combination of four strains of probiotic bacteria contained in the product was directly selected for the treatment of psoriasis.

Earlier in 2021, the company conducted a customer study, where participants who self-identified as suffering from psoriasis reported on positive impacts of the food supplement. 76% of participants who completed the study noticed reduction in itchiness, and 73% reported less irritable skin.

AxisBiotix-Ps is sold in a powder form and can be taken with cold liquids on a daily basis. It does not contain steroids, and is therefore suitable to be taken for longer terms.

Stuart Ashman, CEO of SkinBioTherapeutics, said: “We are delighted that, as of today, we can make AxisBiotix-Ps available to anyone in the US and the UK. Psoriasis can be an excruciating condition, with many suffering with it for decades. After years of scientific research, we now want to support the psoriatic community with a new approach in addressing their symptoms, in the form of a non-prescription-based food supplement, which is straightforward to add to the daily routine. Our consumer study resulted in excellent outcomes in terms of subsidence of redness, itchiness and flakiness among the majority of our participants, and we hope that many more will find relief by using our product.

Sign up for your free email newsletter

”We recognise that it can take a few weeks to notice first changes, therefore we provide two boxes for the price one on all first orders for a limited time.”

Companies